Adipose tissue secretory function: Implication in metabolic and cardiovascular complications of obesity;La fonction sécrétrice du tissu adipeux: Implication dans les complications métaboliques et cardiovasculaires de l'obé sité

Journal de la Societe de Biologie

Volumn 200, Issue 1, 2006, Pages 37-43

  Guerre Millo, Michèle ^a,b,c  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADIPOSE TISSUE; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; HUMAN; MACROPHAGE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; HUMANS; LEPTIN; MACROPHAGES; MODELS, BIOLOGICAL; OBESITY;

EID: 33845640961     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2006005     Document Type: Review

References (47)

1. Ahima R. S. & Flier J. S., Leptin. Annu. Rev. Physiol., 2000, 62, 413-437.
2. Banerjee R. R., Rangwala S. M., Shapiro J. S., Rich A. S., Rhoades B., Qi Y., Wang J., Rajala M. W., Pocai A., Scherer P. E., Steppan C. M., Ahima R. S., Obici S., Rossetti L. & Lazar M. A., Regulation of fasted blood glucose by resistin. Science, 2004, 303, 1195-1198.
3. Bastard J. P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H. & Hainque B., Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab., 2000, 85, 3338-3342.
4. Bastard J. P., Maachi M., Van Nhieu J. T., Jardel C., Bruckert E., Grimaldi A., Robert J. J., Capeau J. & Hainque B., Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab., 2002, 87, 2084-2089.
5. Berg A. H., Combs T. P. & Scherer P. E., ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab., 2002, 13, 84-89.
6. Bouloumie A., Curat C. A., Sengenes C., Lolmede K., Miranville A. & Busse R., Role of macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care, 2005, 8, 347-354.
7. Bruun J. M., Lihn A. S., Verdich C., Pedersen S. B., Toubro S., Astrup A. & Richelsen B., Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am. J. Physiol Endocrinol. Metab., 2003, 285, E527-E533.
8. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J. L., Bouloumie A., Barbatelli G., Cinti S., Svensson P. A., Barsh G. S., Zucker J. D., Basdevant A., Langin D. & Clement K., Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes, 2005, 54, 2277-2286.
9. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L. & Casteilla L., Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem., 2003, 278, 9850-9855.
10. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D. J., Reitman M. L. & Qian S., Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res., 2005, 13, 1311-1320.
11. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A. S. & Obin M. S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res., 2005, 46, 2347-2355.
12. Clement K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C. A., Sicard A., Rome S., Benis A., Zucker J. D., Vidal H., Laville M., Barsh G. S., Basdevant A., Stich V., Cancello R. & Langin D., Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J., 2004, 18, 1657-1669.
13. Combs T. P., Wagner J. A., Berger J., Doebber T., Wang W. J., Zhang B. B., Tanen M., Berg A. H., O'Rahilly S., Savage D. B., Chatterjee K., Weiss S., Larson P. J., Gottesdiener K. M., Gertz B. J., Charron M. J., Scherer P. E. & Moller D. E., Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology, 2002, 143, 998-1007.
14. Curat C. A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R. & Bouloumie A., From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes, 2004, 53, 1285-1292.
15. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., Mohlig M., Pfeiffer A. F., Luft F. C. & Sharma A. M., Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003, 52, 942-947.
16. Fasshauer M., Klein J., Neumann S., Eszlinger M. & Paschke R., Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2002, 290, 1084-1089.
17. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J. & Paschke R., Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2003, 301, 1045-1050.
18. Grosfeld A., Andre J., Hauguel-De Mouzon S., Berra E., Pouyssegur J. & Guerre-Millo M., Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J. Biol. Chem., 2002a, 277, 42953-42957.
19. Grosfeld A., Zilberfarb V., Turban S., Andre J., Guerre-Millo M. & Issad T., Effects of hypoxia on human PAZ6 adipocytes. Diabetologia, 2002b, 45, 527-530.
20. Hainault I., Nebout G., Turban S., Ardouin B., Ferre P. & Quignard-Boulange A., Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am. J. Physiol Endocrinol. Metab., 2002, 282, E59-E66.
21. Hotamisligil G. S., Murray D. L., Choy L. N. & Spiegelman B. M., Tumor necrosis factor á inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA, 1994, 91, 4854-4858.
22. Hotamisligil G. S., Shargill N. S. & Spiegelman B. M., Adipose expression of tumor necrosis factor-á: direct role in obesity-linked insulin resistance. Science, 1993, 259, 87-91.
23. Imai T., Takakuwa R., Marchand S., Dentz E., Bornert J. M., Messaddeq N., Wendling O., Mark M., Desvergne B., Wahli W., Chambon P. & Metzger D., Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. USA, 2004, 101, 4543-4547.
24. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., Manabe I., Utsunomiya K. & Nagai R., Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun., 2004, 314, 415-419.
25. Khovidhunkit W., Kim M. S., Memon R. A., Shigenaga J. K., Moser A. H., Feingold K. R. & Grunfeld C., Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res., 2004, 45, 1169-1196.
26. Kim H. J., Higashimori T., Park S. Y., Choi H., Dong J., Kim Y. J., Noh H. L., Cho Y. R., Cline G., Kim Y. B. & Kim J. K., Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes, 2004, 53, 1060-1067.
27. Lagathu C., Bastard J. P., Auclair M., Maachi M., Capeau J. & Caron M., Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun., 2003, 311, 372-379.
28. Lehrke M., Reilly M. P., Millington S. C., Iqbal N., Rader D. J. & Lazar M., A. An inflammatory cascade leading to hyperresistinemia in humans. Plos. Med., 2004, 1, e45.
29. Loftus T. M., Kuhajda F. P. & Lane M. D., Insulin depletion leads to adipose-specific cell death in obese but not lean mice. Proc. Natl. Acad. Sci. USA, 1998, 95, 14168-14172.
30. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I. & Matsuzawa Y., PPARã ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50, 2094-2099.
31. Massiera F., Bloch-Faure M., Ceiler D., Murakami K., Fukamizu A., Gasc J. M., Quignard-Boulange A., Negrel R., Ailhaud G., Seydoux J., Meneton P. & Teboul M., Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J., 2001, 15, 2727-2729.
32. Minokoshi Y., Kim Y. B., Peroni O. D., Fryer L. G., Muller C., Carling D. & Kahn B. B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 2002, 415, 339-343.
33. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T. & Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100, 2473-2476.
34. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y. & Walsh K., Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol., 2003, 14, 561-566.
35. Qi Y., Takahashi N., Hileman S. M., Patel H. R., Berg A. H., Pajvani U. B., Scherer P. E. & Ahima R. S., Adiponectin acts in the brain to decrease body weight. Nat. Med., 2004, 10, 524-529.
36. Rajala M. W., Obici S., Scherer P. E. & Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest., 2003, 111, 225-230.
37. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S. & Lazar M. A., The hormone resistin links obesity to diabetes. Nature, 2001, 409, 307-312.
38. Steppan C. M., Wang J., Whiteman E. L., Birnbaum M. J. & Lazar M. A., Activation of SOCS-3 by resistin. Mol. Cell Biol., 2005, 25, 1569-1575.
39. Suganami T., Nishida J. & Ogawa Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2062-2068.
40. Tsao T. S., Lodish H. F. & Fruebis J., ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol., 2002, 440, 213-221.
41. Verma S., Li S. H., Wang C. H., Fedak P. W., Li R. K., Weisel R. D. & Mickle D. A., Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation, 2003, 108, 736-740.
42. Villena J. A., Cousin B., Penicaud L. & Casteilla L., Adipose tissues display differential phagocytic and microbicidal activities depending on their localization. Int. J. Obes. Relat. Metab. Disord., 2001, 25, 1275-1280.
43. Weisberg S. P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R. L. & Ferrante A. W., CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest., 2005, in press.
44. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L. & Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest, 2003, 112, 1796-1808.
45. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A. & Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest, 2003, 112, 1821-1830.
46. Yu J. G., Javorschi S., Hevener A. L., Kruszynska Y. T., Norman R. A., Sinha M. & Olefsky J. M., The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002, 51, 2968-2974.
47. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L. & Friedman J. M., Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372, 425-432.